Breaking News Instant updates and real-time market news.

10:01
10/20/20
10/20
10:01
10/20/20
10:01

UBS Brazilian economists to hold a virtual meeting

Brazilian Economists Ramos & Volpon, along with a Brazil Political Consultant from Arko Advice, participate in a virtual meeting on October 20 at 10 am hosted by UBS.

TODAY'S FREE FLY STORIES

Conference/Events
Constellation Pharmaceuticals to hold a pharmceutical update conference call » 17:48
12/05/20
12/05
17:48
12/05/20
17:48
CNST

Constellation Pharmaceuticals

$22.60 /

+0.09 (+0.40%)

Management discusses data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$22.60 /

+0.09 (+0.40%)

CNST Constellation Pharmaceuticals
$22.60 /

+0.09 (+0.40%)

10/30/20 JPMorgan
Constellation added to Analyst Focus List at JPMorgan
09/08/20 Oppenheimer
Constellation Pharmaceuticals downgraded to Perform at Oppenheimer
09/08/20 Oppenheimer
Constellation downgraded to Perform from Outperform at Oppenheimer
09/03/20 Brookline
Constellation Pharmaceuticals initiated with a Buy at Brookline
CNST Constellation Pharmaceuticals
$22.60 /

+0.09 (+0.40%)

  • 17
    Jun
  • 11
    Dec
Conference/Events
CryoLife to hold a pharmaceutical update conference call » 17:45
12/05/20
12/05
17:45
12/05/20
17:45
CRY

CryoLife

$21.58 /

+0.93 (+4.50%)

President & CEO…

President & CEO Mackin and Dr. Alexander, Co-Chair of the PROACT Xa Trial hold a conference call to provide an update on the Trial's progress on December 7 at 4 pm. Webcast Link

ShowHide Related Items >><<
CRY CryoLife
$21.58 /

+0.93 (+4.50%)

CRY CryoLife
$21.58 /

+0.93 (+4.50%)

05/01/20 Lake Street
CryoLife price target raised to $27 from $22 at Lake Street
04/03/20 Lake Street
CryoLife price target lowered to $22 from $38 at Lake Street
04/02/20 Lake Street
CryoLife should emerge stronger in coming years, says Lake Street
04/02/20 Needham
CryoLife price target lowered to $29 from $38 at Needham
CRY CryoLife
$21.58 /

+0.93 (+4.50%)

Conference/Events
JPMorgan leisure/broadlines analyst to hold analyst/industry conference call » 17:30
12/05/20
12/05
17:30
12/05/20
17:30

Leisure/Broadlines &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
British American Tobacco to host conference call » 17:14
12/05/20
12/05
17:14
12/05/20
17:14
BTI

British American Tobacco

$36.94 /

+0.4 (+1.09%)

Management holds a full…

Management holds a full year pre-close trading update conference call on December 9 at 2 am.Webcast Link

ShowHide Related Items >><<
BTI British American Tobacco
$36.94 /

+0.4 (+1.09%)

BTI British American Tobacco
$36.94 /

+0.4 (+1.09%)

09/22/20
Fly Intel: Top five analyst upgrades
09/22/20 RBC Capital
British American Tobacco upgraded to Outperform at RBC Capital
09/22/20 RBC Capital
British American upgraded to Outperform from Sector Perform at RBC Capital
09/02/20 Morgan Stanley
British American Tobacco price target lowered to 3,330 GBp at Morgan Stanley
BTI British American Tobacco
$36.94 /

+0.4 (+1.09%)

BTI British American Tobacco
$36.94 /

+0.4 (+1.09%)

Conference/Events
Roche to hold a conference call » 17:09
12/05/20
12/05
17:09
12/05/20
17:09
RHHBY

Roche

$0.00 /

+ (+0.00%)

Management discusses key…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

11/27/20 UBS
Roche price target lowered to CHF 365 from CHF 370 at UBS
11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Conference/Events
Disney to host virtual investor day » 15:04
12/05/20
12/05
15:04
12/05/20
15:04
DIS

Disney

$154.16 /

+0.95 (+0.62%)

Virtual Investor Day to…

Virtual Investor Day to be held on December 10 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
DIS Disney
$154.16 /

+0.95 (+0.62%)

DIS Disney
$154.16 /

+0.95 (+0.62%)

12/02/20 Citi
Disney price target raised to $175 from $150 at Citi
12/01/20 UBS
Disney price target raised to $155 from $126 at UBS
11/13/20
Fly Intel: Top five analyst upgrades
11/13/20 JPMorgan
Disney price target raised to $160 from $155 at JPMorgan
DIS Disney
$154.16 /

+0.95 (+0.62%)

DIS Disney
$154.16 /

+0.95 (+0.62%)

DIS Disney
$154.16 /

+0.95 (+0.62%)

DIS Disney
$154.16 /

+0.95 (+0.62%)

Conference/Events
Compass Diversified to host Virtual Investor Day » 15:00
12/05/20
12/05
15:00
12/05/20
15:00
CODI

Compass Diversified

$20.24 /

+0.39 (+1.96%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CODI Compass Diversified
$20.24 /

+0.39 (+1.96%)

CODI Compass Diversified
$20.24 /

+0.39 (+1.96%)

07/28/20 Roth Capital
Compass Diversified assumed with a Buy at Roth Capital
04/22/20 Jefferies
Compass Diversified resumed with a Buy at Jefferies
CODI Compass Diversified
$20.24 /

+0.39 (+1.96%)

  • 05
    May
Conference/Events
Edwards Lifesciences to host virtual investor meeting » 14:58
12/05/20
12/05
14:58
12/05/20
14:58
EW

Edwards Lifesciences

$85.76 /

+2.255 (+2.70%)

Virtual Investor Meeting…

Virtual Investor Meeting to be held on December 10 at 12 pm. Webcast Link

ShowHide Related Items >><<
EW Edwards Lifesciences
$85.76 /

+2.255 (+2.70%)

EW Edwards Lifesciences
$85.76 /

+2.255 (+2.70%)

11/18/20 Wells Fargo
Medtronic price target raised to $127 from $118 at Wells Fargo
11/17/20 Piper Sandler
Boston Scientific recall 'positive' for Edwards, Medtronic, says Piper Sandler
10/27/20 Jefferies
Edwards Lifesciences price target raised to $105 from $95 at Jefferies
10/22/20 Credit Suisse
Edwards Lifesciences price target raised to $97 from $92 at Credit Suisse
EW Edwards Lifesciences
$85.76 /

+2.255 (+2.70%)

EW Edwards Lifesciences
$85.76 /

+2.255 (+2.70%)

EW Edwards Lifesciences
$85.76 /

+2.255 (+2.70%)

Conference/Events
MKS Instruments to host virtual analyst day » 14:56
12/05/20
12/05
14:56
12/05/20
14:56
MKSI

MKS Instruments

$151.67 /

+8.61 (+6.02%)

Virtual Analyst Day to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKSI MKS Instruments
$151.67 /

+8.61 (+6.02%)

MKSI MKS Instruments
$151.67 /

+8.61 (+6.02%)

12/01/20 Stifel
Micron's Q1 preannouncement supports recent Stifel channel checks
10/14/20 Stifel
Stifel remains bullish on MKS, highlights exposure to flexible PCB market
09/11/20 Berenberg
MKS Instruments initiated with a Buy at Berenberg
07/31/20 Deutsche Bank
MKS Instruments price target raised to $145 from $130 at Deutsche Bank
MKSI MKS Instruments
$151.67 /

+8.61 (+6.02%)

MKSI MKS Instruments
$151.67 /

+8.61 (+6.02%)

MKSI MKS Instruments
$151.67 /

+8.61 (+6.02%)

Conference/Events
Netgear to host virtual analyst day » 14:54
12/05/20
12/05
14:54
12/05/20
14:54
NTGR

Netgear

$34.17 /

+0.46 (+1.36%)

Virtual Analyst Day to be…

Virtual Analyst Day to be held on December 10 at 11 am. Webcast Link

ShowHide Related Items >><<
NTGR Netgear
$34.17 /

+0.46 (+1.36%)

NTGR Netgear
$34.17 /

+0.46 (+1.36%)

10/22/20 Cowen
Netgear price target raised to $43 from $35 at Cowen
10/22/20 Deutsche Bank
Netgear price target raised to $39 from $32 at Deutsche Bank
07/23/20 BWS Financial
Netgear price target raised to $45 from $33 at BWS Financial
07/23/20 Deutsche Bank
Netgear price target raised to $32 from $25 at Deutsche Bank
NTGR Netgear
$34.17 /

+0.46 (+1.36%)

NTGR Netgear
$34.17 /

+0.46 (+1.36%)

Conference/Events
Mosaic to host virtual analyst presentation » 14:50
12/05/20
12/05
14:50
12/05/20
14:50
MOS

Mosaic

$22.77 /

+1.56 (+7.36%)

Analyst Presentation III…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MOS Mosaic
$22.77 /

+1.56 (+7.36%)

MOS Mosaic
$22.77 /

+1.56 (+7.36%)

11/25/20 VTB Capital
Mosaic downgraded to Sell from Hold at VTB Capital
11/24/20 Bernstein
Commerce rules in Mosaic's favor on CVD complaint, says Bernstein
11/03/20 Scotiabank
Mosaic downgraded to Sector Perform from Outperform at Scotiabank
10/21/20 Citi
Mosaic downgraded to Neutral from Buy at Citi
MOS Mosaic
$22.77 /

+1.56 (+7.36%)

MOS Mosaic
$22.77 /

+1.56 (+7.36%)

MOS Mosaic
$22.77 /

+1.56 (+7.36%)

Conference/Events
Astec to host virtual investor day » 14:23
12/05/20
12/05
14:23
12/05/20
14:23
ASTE

Astec

$62.38 /

+2.92 (+4.91%)

Virtual Investor Day to…

Virtual Investor Day to be held on December 10 at 9 am. Webcast Link

ShowHide Related Items >><<
ASTE Astec
$62.38 /

+2.92 (+4.91%)

ASTE Astec
$62.38 /

+2.92 (+4.91%)

04/23/20 Sidoti
Astec downgraded to Neutral with $41 price target at Sidoti
04/23/20 Sidoti
Astec downgraded to Neutral from Buy at Sidoti
04/01/20 Baird
Astec upgraded to Outperform at Baird
04/01/20 Baird
Astec upgraded to Outperform from Neutral at Baird
ASTE Astec
$62.38 /

+2.92 (+4.91%)

Conference/Events
Broadridge to host virtual investor meeting » 14:22
12/05/20
12/05
14:22
12/05/20
14:22
BR

Broadridge

$149.20 /

+1.26 (+0.85%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$149.20 /

+1.26 (+0.85%)

BR Broadridge
$149.20 /

+1.26 (+0.85%)

08/17/20 JPMorgan
Broadridge price target raised to $152 from $142 at JPMorgan
08/12/20
Fly Intel: Top five analyst downgrades
08/11/20 BTIG
Broadridge downgraded to Neutral from Buy at BTIG
08/11/20 BTIG
Broadridge downgraded to Neutral from Buy at BTIG
BR Broadridge
$149.20 /

+1.26 (+0.85%)

Conference/Events
Medicenna Therapeutics to hold a conference call » 14:11
12/05/20
12/05
14:11
12/05/20
14:11
MDNA

Medicenna Therapeutics

$3.87 /

-0.11 (-2.76%)

Management holds a Key…

Management holds a Key Opinion Leader conference call to discuss MDNA55 for treatment of recurrent Glioblastoma Multiforme (rGBM) to be held on December 11 at 11 am. Webcast Link

ShowHide Related Items >><<
MDNA Medicenna Therapeutics
$3.87 /

-0.11 (-2.76%)

MDNA Medicenna Therapeutics
$3.87 /

-0.11 (-2.76%)

09/10/20 H.C. Wainwright
Medicenna Therapeutics initiated with a Buy at H.C. Wainwright
MDNA Medicenna Therapeutics
$3.87 /

-0.11 (-2.76%)

MDNA Medicenna Therapeutics
$3.87 /

-0.11 (-2.76%)

Conference/Events
American Society of Hematology (ASH) to hold a virtual meeting » 13:56
12/05/20
12/05
13:56
12/05/20
13:56
SDGR

Schrodinger

$66.08 /

+1.34 (+2.07%)

, TRIL

Trillium Therapeutics

$17.06 /

-0.97 (-5.38%)

, FRLN

Freeline

$16.47 /

+0.25 (+1.54%)

, SNDX

Syndax

$24.59 /

+0.5 (+2.08%)

, ADAP

Adaptimmune

$4.46 /

-0.04 (-0.89%)

, NEO

NeoGenomics

$48.00 /

+0.13 (+0.27%)

, MOR

MorphoSys

$28.40 /

+0.22 (+0.78%)

, MNTA

Bought by JNJ

$52.49 /

+ (+0.00%)

, SNY

Sanofi

$51.01 /

+0.97 (+1.94%)

, REGN

Regeneron

$492.10 /

-6.61 (-1.33%)

, SGEN

Seagen

$179.37 /

-0.625 (-0.35%)

, RCKT

Rocket Pharmaceuticals

$32.02 /

-1.78 (-5.27%)

, VRTX

Vertex Pharmaceuticals

$228.24 /

+1.58 (+0.70%)

, PFE

Pfizer

$40.36 /

+0.26 (+0.65%)

, KDMN

Kadmon

$4.17 /

+0.1 (+2.46%)

, KPTI

Karyopharm

$16.26 /

-0.38 (-2.28%)

, GILD

Gilead

$61.57 /

+0.7 (+1.15%)

, KURA

Kura Oncology

$36.79 /

+2.78 (+8.17%)

, JAZZ

Jazz Pharmaceuticals

$150.58 /

-0.4 (-0.26%)

, JNJ

Johnson & Johnson

$150.30 /

+1.35 (+0.91%)

, NVS

Novartis

$91.58 /

+1.35 (+1.50%)

, NVO

Novo Nordisk

$67.82 /

+0.62 (+0.92%)

, FMTX

Forma Therapeutics

$43.53 /

-0.26 (-0.59%)

, AZN

AstraZeneca

$53.71 /

+0.93 (+1.76%)

, EPZM

Epizyme

$13.06 /

+0.04 (+0.31%)

, FATE

Fate Therapeutics

$60.68 /

+0.29 (+0.48%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, CRSP

Crispr Therapeutics

$147.30 /

+6.74 (+4.80%)

, BMRN

BioMarin

$79.62 /

+0.53 (+0.67%)

, BLUE

Bluebird Bio

$46.91 /

-0.13 (-0.28%)

, BGNE

BeiGene

$222.79 /

+1.61 (+0.73%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, ALLO

Allogene Therapeutics

$33.56 /

+1.27 (+3.93%)

, AMGN

Amgen

$229.13 /

+2.23 (+0.98%)

62nd Virtual Annual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$228.24 /

+1.58 (+0.70%)

TRIL Trillium Therapeutics
$17.06 /

-0.97 (-5.38%)

SNY Sanofi
$51.01 /

+0.97 (+1.94%)

SNDX Syndax
$24.59 /

+0.5 (+2.08%)

SGEN Seagen
$179.37 /

-0.625 (-0.35%)

SDGR Schrodinger
$66.08 /

+1.34 (+2.07%)

REGN Regeneron
$492.10 /

-6.61 (-1.33%)

RCKT Rocket Pharmaceuticals
$32.02 /

-1.78 (-5.27%)

PFE Pfizer
$40.36 /

+0.26 (+0.65%)

NVS Novartis
$91.58 /

+1.35 (+1.50%)

NVO Novo Nordisk
$67.82 /

+0.62 (+0.92%)

NEO NeoGenomics
$48.00 /

+0.13 (+0.27%)

MOR MorphoSys
$28.40 /

+0.22 (+0.78%)

MNTA Bought by JNJ
$52.49 /

+ (+0.00%)

KURA Kura Oncology
$36.79 /

+2.78 (+8.17%)

KPTI Karyopharm
$16.26 /

-0.38 (-2.28%)

KDMN Kadmon
$4.17 /

+0.1 (+2.46%)

JNJ Johnson & Johnson
$150.30 /

+1.35 (+0.91%)

JAZZ Jazz Pharmaceuticals
$150.58 /

-0.4 (-0.26%)

GILD Gilead
$61.57 /

+0.7 (+1.15%)

FRLN Freeline
$16.47 /

+0.25 (+1.54%)

FMTX Forma Therapeutics
$43.53 /

-0.26 (-0.59%)

FATE Fate Therapeutics
$60.68 /

+0.29 (+0.48%)

EPZM Epizyme
$13.06 /

+0.04 (+0.31%)

CRSP Crispr Therapeutics
$147.30 /

+6.74 (+4.80%)

BMRN BioMarin
$79.62 /

+0.53 (+0.67%)

BLUE Bluebird Bio
$46.91 /

-0.13 (-0.28%)

BGNE BeiGene
$222.79 /

+1.61 (+0.73%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.71 /

+0.93 (+1.76%)

AMGN Amgen
$229.13 /

+2.23 (+0.98%)

ALLO Allogene Therapeutics
$33.56 /

+1.27 (+3.93%)

ADAP Adaptimmune
$4.46 /

-0.04 (-0.89%)

SDGR Schrodinger
$66.08 /

+1.34 (+2.07%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/23/20 BofA
Schrodinger upgraded to Buy from Neutral at BofA
10/12/20 Jefferies
Schrodinger upgraded to Buy from Hold at Jefferies
08/10/20
Schrodinger files to sell 4.5M shares of common stock
TRIL Trillium Therapeutics
$17.06 /

-0.97 (-5.38%)

11/18/20 Craig-Hallum
Trillium Therapeutics price target raised to $21 from $15 at Craig-Hallum
11/04/20 Cowen
Trillium ASH abstracts provide 'minimal updates', says Cowen
10/12/20 Evercore ISI
Trillium Therapeutics initiated with an Outperform at Evercore ISI
10/05/20 Piper Sandler
Patent fight likely to weigh on ALX Oncology shares NT, says Piper Sandler
FRLN Freeline
$16.47 /

+0.25 (+1.54%)

11/25/20 Redburn
Freeline initiated with a Neutral at Redburn
09/01/20 Evercore ISI
Freeline initiated with an Outperform at Evercore ISI
09/01/20 Wedbush
Wedbush bullish on Freeline, initiates with an Outperform
09/01/20 Wedbush
Freeline initiated with an Outperform at Wedbush
SNDX Syndax
$24.59 /

+0.5 (+2.08%)

12/02/20 Stifel
Syndax initiated with a Buy at Stifel
11/19/20 Barclays
Syndax price target raised to $29 from $23 at Barclays
05/22/20 H.C. Wainwright
Syndax downgraded to Neutral from Buy at H.C. Wainwright
05/22/20 H.C. Wainwright
Syndax downgraded to Neutral from Buy at H.C. Wainwright
ADAP Adaptimmune
$4.46 /

-0.04 (-0.89%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
NEO NeoGenomics
$48.00 /

+0.13 (+0.27%)

11/20/20 SVB Leerink
NeoGenomics price target raised to $50 from $47 at SVB Leerink
10/28/20 Needham
NeoGenomics price target raised to $46 from $39 at Needham
10/28/20 Craig-Hallum
NeoGenomics price target raised to $50 from $42 at Craig-Hallum
09/09/20 Morgan Stanley
NeoGenomics initiated with an Overweight at Morgan Stanley
MOR MorphoSys
$28.40 /

+0.22 (+0.78%)

11/25/20
Fly Intel: Top five analyst initiations
11/25/20 Morgan Stanley
MorphoSys initiated with an Equal Weight at Morgan Stanley
11/18/20 Goldman Sachs
MorphoSys initiated with a Neutral at Goldman Sachs
11/13/20 Barclays
MorphoSys price target lowered to EUR 90 from EUR 110 at Barclays
MNTA Bought by JNJ
$52.49 /

+ (+0.00%)

08/25/20 Baird
Immunovant price target raised to $47 from $31 at Baird
08/25/20 Chardan
Immunovant price target raised to $45 from $35 at Chardan
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
SNY Sanofi
$51.01 /

+0.97 (+1.94%)

11/30/20 Morgan Stanley
AbbVie price target raised to $120 from $108 at Morgan Stanley
11/03/20 Morgan Stanley
Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley
10/30/20 JPMorgan
Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
REGN Regeneron
$492.10 /

-6.61 (-1.33%)

11/23/20 Piper Sandler
Regeneron Covid cocktail could be meaningful to earnings, says Piper Sandler
11/11/20 Truist
Opthea initiated with a Buy at Truist
11/10/20 SVB Leerink
Regeneron price target lowered to $643 from $653 at SVB Leerink
SGEN Seagen
$179.37 /

-0.625 (-0.35%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/22/20 JMP Securities
Seattle Genetics price target raised to $200 from $185 at JMP Securities
09/21/20 Piper Sandler
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler
RCKT Rocket Pharmaceuticals
$32.02 /

-1.78 (-5.27%)

11/23/20 JPMorgan
Rocket Pharmaceuticals price target raised to $43 from $38 at JPMorgan
10/16/20 Chardan
Rocket update illustrates optimized manufacturing, says Chardan
10/16/20 Piper Sandler
Piper Sandler 'encouraged' by Rocket Pharmaceuticals' ESID updates
09/22/20 Oppenheimer
Rocket Pharmaceuticals price target lowered to $33 from $43 at Oppenheimer
VRTX Vertex Pharmaceuticals
$228.24 /

+1.58 (+0.70%)

11/30/20 RBC Capital
Vertex Pharmaceuticals upgraded to Outperform from Sector Perform at RBC Capital
11/30/20 RBC Capital
Vertex upgraded to Outperform from Sector Perform at RBC Capital
11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
Vertex Pharmaceuticals initiated with an Outperform at Bernstein
PFE Pfizer
$40.36 /

+0.26 (+0.65%)

12/04/20 Barclays
Pfizer price target raised to $37 from $35 at Barclays
12/01/20 Morgan Stanley
COVID mRNA vaccines seen with vast majority of U.S. market, says Morgan Stanley
11/30/20 BofA
BofA downgrades BioNTech to Neutral with 'best in class' vaccine seen priced in
11/27/20 Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
KDMN Kadmon
$4.17 /

+0.1 (+2.46%)

11/11/20
Fly Intel: Top five analyst initiations
11/11/20 Mizuho
Kadmon initiated with a Buy, $13 price target at Mizuho
11/10/20 Mizuho
Kadmon initiated with a Buy at Mizuho
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
KPTI Karyopharm
$16.26 /

-0.38 (-2.28%)

09/25/20 RBC Capital
Karyopharm shares undervalued as seli moves into MF, says RBC Capital
07/01/20 Morgan Stanley
Karyopharm initiated with an Overweight at Morgan Stanley
06/23/20 JPMorgan
Karyopharm price target raised to $37 from $31 at JPMorgan
06/23/20 RBC Capital
Karyopharm price target raised to $30 from $28 at RBC Capital
GILD Gilead
$61.57 /

+0.7 (+1.15%)

11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Berenberg
Arcus Biosciences initiated with a Buy at Berenberg
11/20/20 Raymond James
Use of Gilead's remdesivir likely to skew to U.S. into Q1, says Raymond James
11/03/20
Fly Intel: Top five analyst initiations
KURA Kura Oncology
$36.79 /

+2.78 (+8.17%)

12/02/20 Stifel
Kura Oncology initiated with a Buy at Stifel
11/05/20 Piper Sandler
Piper downgrades Kura Oncology to Neutral with KO-539 expectations priced in
11/05/20 Piper Sandler
Kura Oncology downgraded to Neutral from Overweight at Piper Sandler
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
JAZZ Jazz Pharmaceuticals
$150.58 /

-0.4 (-0.26%)

11/03/20 SVB Leerink
Jazz Pharmaceuticals price target raised to $202 from $194 at SVB Leerink
11/03/20 Wells Fargo
Jazz Pharmaceuticals price target raised to $184 from $171 at Wells Fargo
11/03/20 RBC Capital
Jazz Pharmaceuticals price target raised to $180 from $170 at RBC Capital
11/03/20 Barclays
Jazz Pharmaceuticals price target raised to $233 from $225 at Barclays
JNJ Johnson & Johnson
$150.30 /

+1.35 (+0.91%)

11/24/20 Raymond James
Intuitive Surgical not surprised by J&J robot features, says Raymond James
11/23/20 SVB Leerink
AstraZeneca vaccine 'will never be licensed in the U.S.,' says SVB Leerink
11/12/20 Chardan
Immunovant price target raised to $60 from $45 at Chardan
11/10/20 Piper Sandler
Aligos Therapeutics initiated with an Overweight at Piper Sandler
NVS Novartis
$91.58 /

+1.35 (+1.50%)

12/03/20 Argus
Novartis price target raised to $112 from $100 at Argus
11/25/20 UBS
Novartis price target raised to CHF 99 from CHF 98 at UBS
11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
NVO Novo Nordisk
$67.82 /

+0.62 (+0.92%)

11/16/20 Piper Sandler
Piper says 'underwhelming' data from Novo Nordisk a 'big win' for Intercept
11/12/20 JPMorgan
Novo Nordisk price target lowered to DKK 470 from DKK 480 at JPMorgan
11/06/20 Morgan Stanley
Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley
11/03/20 Societe Generale
Novo Nordisk price target raised to DKK 390 from DKK 370 at Societe Generale
FMTX Forma Therapeutics
$43.53 /

-0.26 (-0.59%)

11/19/20 Cantor Fitzgerald
Forma Therapeutics initiated with an Overweight at Cantor Fitzgerald
11/18/20 Cantor Fitzgerald
Forma Therapeutics initiated with an Overweight at Cantor Fitzgerald
09/08/20 H.C. Wainwright
Forma Therapeutics initiated with a Buy at H.C. Wainwright
07/14/20 SVB Leerink
Forma Therapeutics initiated with an Outperform at SVB Leerink
AZN AstraZeneca
$53.71 /

+0.93 (+1.76%)

11/30/20 UBS
AstraZeneca upgraded to Neutral from Sell at UBS
11/27/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff
EPZM Epizyme
$13.06 /

+0.04 (+0.31%)

11/09/20 Barclays
Epizyme price target lowered to $18 from $33 at Barclays
10/05/20 Citi
Citi highlights Epizyme, Karuna as potential targets after MyoKardia takeover
06/19/20 Citi
Epizyme should be bought on any confusion over label, at Citi
06/18/20 Jefferies
Jefferies sees broad approval for Epizyme's Taz as 'fundamental positive'
FATE Fate Therapeutics
$60.68 /

+0.29 (+0.48%)

12/02/20 Barclays
Fate Therapeutics price target raised to $70 from $60 at Barclays
11/24/20 Truist
Fate Therapeutics price target raised to $65 from $40 at Truist
11/09/20 Citi
Fate Therapeutics price target raised to $63 from $40 at Citi
11/08/20 Oppenheimer
Fate Therapeutics price target raised to $60 from $40 at Oppenheimer
DNA Bought by RHHBY
$0.00 /

+ (+0.00%)

CRSP Crispr Therapeutics
$147.30 /

+6.74 (+4.80%)

11/04/20 Roth Capital
Crispr Therapeutics data early, but show CTX001's potential, says Roth Capital
11/04/20 Piper Sandler
Crispr Therapeutics' CTX001 abstract shows longer durability, says Piper Sandler
11/02/20 Baird
Baird starts Editas Medicine with Underperform, $14 price target
10/28/20 Piper Sandler
Crispr Therapeutics price target lowered to $107 from $128 at Piper Sandler
BMRN BioMarin
$79.62 /

+0.53 (+0.67%)

11/03/20 Piper Sandler
Piper Sandler remains buyer of BioMarin after vosoritide submission
10/22/20 RBC Capital
uniQure initiated with an Outperform at RBC Capital
09/10/20 Truist
BioMarin price target lowered to $125 from $130 at Truist
08/25/20 JPMorgan
Sarepta added to Analyst Focus List, named a Top Idea at JPMorgan
BLUE Bluebird Bio
$46.91 /

-0.13 (-0.28%)

11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Bluebird Bio initiated with a Buy at Berenberg
11/06/20 Wedbush
Bluebird Bio price target lowered to $73 from $81 at Wedbush
BGNE BeiGene
$222.79 /

+1.61 (+0.73%)

11/19/20 SVB Leerink
BeiGene price target raised to $327 from $240 at SVB Leerink
11/09/20 Maxim
BeiGene downgraded to Hold from Buy at Maxim
11/09/20 Ladenburg
BeiGene downgraded to Neutral from Buy at Ladenburg
11/06/20 Maxim
BeiGene downgraded to Hold from Buy at Maxim
BAYRY Bayer
$0.00 /

+ (+0.00%)

11/06/20 Morgan Stanley
Bayer price target lowered to EUR 67 from EUR 68 at Morgan Stanley
11/05/20 Deutsche Bank
Bayer price target lowered to EUR 62 from EUR 64 at Deutsche Bank
11/05/20 JPMorgan
Bayer price target lowered to EUR 52 from EUR 77 at JPMorgan
11/04/20 Credit Suisse
Bayer price target lowered to EUR 47 from EUR 50 at Credit Suisse
ALLO Allogene Therapeutics
$33.56 /

+1.27 (+3.93%)

11/24/20 BofA
Allogene Therapeutics initiated with a Buy at BofA
11/24/20 BofA
Allogene Therapeutics initiated with a Buy at BofA
11/04/20 Oppenheimer
Allogene weakness after abstract a buying opportunity, says Oppenheimer
11/04/20 Roth Capital
Question of safety with Allogene's Allo-CARs may be premature, says Roth Capital
AMGN Amgen
$229.13 /

+2.23 (+0.98%)

11/23/20 Mizuho
Cytokinetics regaining omecamtiv could add $3 per share, says Mizuho
11/23/20 H.C. Wainwright
Cytokinetics price target lowered to $22 from $43 at H.C. Wainwright
11/23/20 Piper Sandler
Piper keeps $25 target on Cytokinetics after Amgen returns omecamtiv mecarbil
11/16/20 Oppenheimer
Amgen price target lowered to $274 from $280 at Oppenheimer
VRTX Vertex Pharmaceuticals
$228.24 /

+1.58 (+0.70%)

TRIL Trillium Therapeutics
$17.06 /

-0.97 (-5.38%)

SNY Sanofi
$51.01 /

+0.97 (+1.94%)

SNDX Syndax
$24.59 /

+0.5 (+2.08%)

SGEN Seagen
$179.37 /

-0.625 (-0.35%)

SDGR Schrodinger
$66.08 /

+1.34 (+2.07%)

REGN Regeneron
$492.10 /

-6.61 (-1.33%)

RCKT Rocket Pharmaceuticals
$32.02 /

-1.78 (-5.27%)

PFE Pfizer
$40.36 /

+0.26 (+0.65%)

NVS Novartis
$91.58 /

+1.35 (+1.50%)

NVO Novo Nordisk
$67.82 /

+0.62 (+0.92%)

NEO NeoGenomics
$48.00 /

+0.13 (+0.27%)

MOR MorphoSys
$28.40 /

+0.22 (+0.78%)

MNTA Bought by JNJ
$52.49 /

+ (+0.00%)

KURA Kura Oncology
$36.79 /

+2.78 (+8.17%)

KPTI Karyopharm
$16.26 /

-0.38 (-2.28%)

KDMN Kadmon
$4.17 /

+0.1 (+2.46%)

JNJ Johnson & Johnson
$150.30 /

+1.35 (+0.91%)

JAZZ Jazz Pharmaceuticals
$150.58 /

-0.4 (-0.26%)

GILD Gilead
$61.57 /

+0.7 (+1.15%)

FMTX Forma Therapeutics
$43.53 /

-0.26 (-0.59%)

FATE Fate Therapeutics
$60.68 /

+0.29 (+0.48%)

EPZM Epizyme
$13.06 /

+0.04 (+0.31%)

CRSP Crispr Therapeutics
$147.30 /

+6.74 (+4.80%)

BMRN BioMarin
$79.62 /

+0.53 (+0.67%)

BLUE Bluebird Bio
$46.91 /

-0.13 (-0.28%)

BGNE BeiGene
$222.79 /

+1.61 (+0.73%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.71 /

+0.93 (+1.76%)

AMGN Amgen
$229.13 /

+2.23 (+0.98%)

ALLO Allogene Therapeutics
$33.56 /

+1.27 (+3.93%)

ADAP Adaptimmune
$4.46 /

-0.04 (-0.89%)

  • 02
    Dec
  • 11
    Sep
  • 13
    Aug
  • 07
    Aug
  • 01
    Jul
  • 19
    Jun
  • 09
    Jun
  • 02
    Jun
  • 02
    Jun
  • 27
    May
  • 19
    May
  • 06
    May
  • 30
    Apr
  • 30
    Apr
  • 04
    Mar
  • 06
    Feb
  • 23
    Jan
  • 22
    Jan
  • 12
    Dec
  • 11
    Dec
VRTX Vertex Pharmaceuticals
$228.24 /

+1.58 (+0.70%)

SNY Sanofi
$51.01 /

+0.97 (+1.94%)

REGN Regeneron
$492.10 /

-6.61 (-1.33%)

PFE Pfizer
$40.36 /

+0.26 (+0.65%)

NVS Novartis
$91.58 /

+1.35 (+1.50%)

MOR MorphoSys
$28.40 /

+0.22 (+0.78%)

JNJ Johnson & Johnson
$150.30 /

+1.35 (+0.91%)

GILD Gilead
$61.57 /

+0.7 (+1.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.71 /

+0.93 (+1.76%)

AMGN Amgen
$229.13 /

+2.23 (+0.98%)

VRTX Vertex Pharmaceuticals
$228.24 /

+1.58 (+0.70%)

TRIL Trillium Therapeutics
$17.06 /

-0.97 (-5.38%)

SNY Sanofi
$51.01 /

+0.97 (+1.94%)

SGEN Seagen
$179.37 /

-0.625 (-0.35%)

SDGR Schrodinger
$66.08 /

+1.34 (+2.07%)

REGN Regeneron
$492.10 /

-6.61 (-1.33%)

PFE Pfizer
$40.36 /

+0.26 (+0.65%)

NVS Novartis
$91.58 /

+1.35 (+1.50%)

NVO Novo Nordisk
$67.82 /

+0.62 (+0.92%)

MNTA Bought by JNJ
$52.49 /

+ (+0.00%)

KPTI Karyopharm
$16.26 /

-0.38 (-2.28%)

KDMN Kadmon
$4.17 /

+0.1 (+2.46%)

JNJ Johnson & Johnson
$150.30 /

+1.35 (+0.91%)

GILD Gilead
$61.57 /

+0.7 (+1.15%)

FRLN Freeline
$16.47 /

+0.25 (+1.54%)

FMTX Forma Therapeutics
$43.53 /

-0.26 (-0.59%)

EPZM Epizyme
$13.06 /

+0.04 (+0.31%)

CRSP Crispr Therapeutics
$147.30 /

+6.74 (+4.80%)

BMRN BioMarin
$79.62 /

+0.53 (+0.67%)

BLUE Bluebird Bio
$46.91 /

-0.13 (-0.28%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.71 /

+0.93 (+1.76%)

AMGN Amgen
$229.13 /

+2.23 (+0.98%)

ALLO Allogene Therapeutics
$33.56 /

+1.27 (+3.93%)

VRTX Vertex Pharmaceuticals
$228.24 /

+1.58 (+0.70%)

TRIL Trillium Therapeutics
$17.06 /

-0.97 (-5.38%)

SDGR Schrodinger
$66.08 /

+1.34 (+2.07%)

REGN Regeneron
$492.10 /

-6.61 (-1.33%)

PFE Pfizer
$40.36 /

+0.26 (+0.65%)

NVO Novo Nordisk
$67.82 /

+0.62 (+0.92%)

MNTA Bought by JNJ
$52.49 /

+ (+0.00%)

JNJ Johnson & Johnson
$150.30 /

+1.35 (+0.91%)

GILD Gilead
$61.57 /

+0.7 (+1.15%)

BMRN BioMarin
$79.62 /

+0.53 (+0.67%)

AZN AstraZeneca
$53.71 /

+0.93 (+1.76%)

AMGN Amgen
$229.13 /

+2.23 (+0.98%)

ADAP Adaptimmune
$4.46 /

-0.04 (-0.89%)

Conference/Events
Zscaler to hold a virtual event » 13:54
12/05/20
12/05
13:54
12/05/20
13:54
ZS

Zscaler

$180.76 /

-4.99 (-2.69%)

Virtual Analyst Event…

Virtual Analyst Event 2020 will be held on December 9 at 3 pm. Webcast Link

ShowHide Related Items >><<
ZS Zscaler
$180.76 /

-4.99 (-2.69%)

ZS Zscaler
$180.76 /

-4.99 (-2.69%)

12/03/20 Loop Capital
Zscaler price target raised to $215 from $170 at Loop Capital
12/03/20 Credit Suisse
Zscaler price target raised to $175 from $160 at Credit Suisse
12/03/20 Wedbush
Zscaler price target raised to $185 from $175 at Wedbush
12/03/20 DA Davidson
Zscaler price target raised to $185 from $155 at DA Davidson
ZS Zscaler
$180.76 /

-4.99 (-2.69%)

ZS Zscaler
$180.76 /

-4.99 (-2.69%)

ZS Zscaler
$180.76 /

-4.99 (-2.69%)

ZS Zscaler
$180.76 /

-4.99 (-2.69%)

Conference/Events
DexCom to host virtual investor day » 13:51
12/05/20
12/05
13:51
12/05/20
13:51
DXCM

DexCom

$348.24 /

+3.55 (+1.03%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$348.24 /

+3.55 (+1.03%)

DXCM DexCom
$348.24 /

+3.55 (+1.03%)

12/01/20 Baird
DexCom weakness creates compelling buying opportunity, says Baird
11/20/20 Piper Sandler
DexCom secured national reimbursement in France, says Piper Sandler
10/28/20 Canaccord
DexCom price target lowered to $475 from $500 at Canaccord
10/28/20 Raymond James
DexCom price target lowered to $438 from $450 at Raymond James
DXCM DexCom
$348.24 /

+3.55 (+1.03%)

DXCM DexCom
$348.24 /

+3.55 (+1.03%)

On The Fly
Charged: Goldman says buy Tesla, USPS delays decision on NGDV » 08:49
12/05/20
12/05
08:49
12/05/20
08:49
TSLA

Tesla

$599.00 /

+5.95 (+1.00%)

, WKHS

Workhorse Group

$22.07 /

-0.585 (-2.58%)

, NKLA

Nikola

$18.86 /

-0.14 (-0.74%)

, PLUG

Plug Power

$24.85 /

+1 (+4.19%)

, XPEV

Xpeng

$49.42 /

-2.065 (-4.01%)

, NIO

NIO Inc.

$43.01 /

-2.29 (-5.06%)

, BLNK

Blink Charging

$23.84 /

+1.19 (+5.25%)

, QSR

Restaurant Brands

$60.50 /

+1.68 (+2.86%)

, GM

General Motors

$44.38 /

+0.31 (+0.70%)

Welcome to The Fly's…

ShowHide Related Items >><<
XPEV Xpeng
$49.42 /

-2.065 (-4.01%)

WKHS Workhorse Group
$22.07 /

-0.585 (-2.58%)

TSLA Tesla
$599.00 /

+5.95 (+1.00%)

QSR Restaurant Brands
$60.50 /

+1.68 (+2.86%)

PLUG Plug Power
$24.85 /

+1 (+4.19%)

NKLA Nikola
$18.86 /

-0.14 (-0.74%)

NIO NIO Inc.
$43.01 /

-2.29 (-5.06%)

GM General Motors
$44.38 /

+0.31 (+0.70%)

BLNK Blink Charging
$23.84 /

+1.19 (+5.25%)

TSLA Tesla
$599.00 /

+5.95 (+1.00%)

12/03/20
Fly Intel: Top five analyst upgrades
12/02/20 Goldman Sachs
Tesla upgraded to Buy from Neutral at Goldman Sachs
11/27/20 BofA
BofA positive on long-term share gains for NIO Inc. after hosting calls
11/18/20
Fly Intel: Top five analyst upgrades
WKHS Workhorse Group
$22.07 /

-0.585 (-2.58%)

12/02/20 Roth Capital
USPS delay gives Workhorse competitors more time, says Roth Capital
11/16/20
Workhorse Group initiated with a Buy at Lafferty
11/10/20 Roth Capital
Workhorse Group price target lowered to $19 from $27 at Roth Capital
10/26/20 Vertical Group
Workhorse Group initiated with a Sell at Vertical Group
NKLA Nikola
$18.86 /

-0.14 (-0.74%)

12/04/20 Deutsche Bank
Nikola sees no deterioration in Bosch relationship, says Deutsche Bank
12/01/20 Deutsche Bank
GM no longer wants to be tied to Nikola's longer term outlook, says Deutsche
11/30/20 Cowen
Nikola deal with GM being mischaracterized, is a positive, says Cowen
11/30/20 JPMorgan
Nikola pullback could be a good buying opportunity, says JPMorgan
PLUG Plug Power
$24.85 /

+1 (+4.19%)

11/30/20 Roth Capital
Plug Power price target raised to $30 from $22 at Roth Capital
11/12/20 Canaccord
Plug Power price target raised to $25 from $13 at Canaccord
11/10/20 Craig-Hallum
Plug Power price target raised to $26 from $14 at Craig-Hallum
11/10/20 B. Riley Securities
Plug Power price target raised to $24 from $18 at B. Riley Securities
XPEV Xpeng
$49.42 /

-2.065 (-4.01%)

12/02/20 UBS
UBS downgrades Xpeng to Neutral, raises price target to $59
12/02/20 UBS
Xpeng downgraded to Neutral from Buy at UBS
11/16/20 Citi
Xpeng price target raised to $57.71 from $34.70 at Citi
11/09/20 JPMorgan
Xpeng price target raised to $43 from $27 at JPMorgan
NIO NIO Inc.
$43.01 /

-2.29 (-5.06%)

12/01/20
Fly Intel: Top five analyst upgrades
12/01/20 Goldman Sachs
NIO Inc. upgraded to Neutral from Sell at Goldman Sachs
BLNK Blink Charging
$23.84 /

+1.19 (+5.25%)

08/14/20
Fly Intel: Top five analyst downgrades
08/14/20 H.C. Wainwright
Blink Charging downgraded to Neutral from Buy at H.C. Wainwright
QSR Restaurant Brands
$60.50 /

+1.68 (+2.86%)

11/20/20 Stifel
Vaccine could aid recovery for urban-exposed restaurant chains, says Stifel
11/03/20 Stephens
Restaurant Brands resumed with an Equal Weight at Stephens
10/28/20 Baird
Restaurant Brands price target lowered to $60 from $69 at Baird
10/15/20
Fly Intel: Top five analyst downgrades
GM General Motors
$44.38 /

+0.31 (+0.70%)

11/30/20 Wedbush
Wedbush keeps Underperform rating on Nikola as revised GM deal disappoints
XPEV Xpeng
$49.42 /

-2.065 (-4.01%)

WKHS Workhorse Group
$22.07 /

-0.585 (-2.58%)

TSLA Tesla
$599.00 /

+5.95 (+1.00%)

QSR Restaurant Brands
$60.50 /

+1.68 (+2.86%)

PLUG Plug Power
$24.85 /

+1 (+4.19%)

NKLA Nikola
$18.86 /

-0.14 (-0.74%)

NIO NIO Inc.
$43.01 /

-2.29 (-5.06%)

GM General Motors
$44.38 /

+0.31 (+0.70%)

BLNK Blink Charging
$23.84 /

+1.19 (+5.25%)

  • 17
    Nov
  • 31
    Aug
  • 27
    Aug
  • 12
    Aug
  • 11
    Jun
  • 14
    Feb
  • 06
    Dec
XPEV Xpeng
$49.42 /

-2.065 (-4.01%)

WKHS Workhorse Group
$22.07 /

-0.585 (-2.58%)

TSLA Tesla
$599.00 /

+5.95 (+1.00%)

QSR Restaurant Brands
$60.50 /

+1.68 (+2.86%)

PLUG Plug Power
$24.85 /

+1 (+4.19%)

NKLA Nikola
$18.86 /

-0.14 (-0.74%)

NIO NIO Inc.
$43.01 /

-2.29 (-5.06%)

GM General Motors
$44.38 /

+0.31 (+0.70%)

BLNK Blink Charging
$23.84 /

+1.19 (+5.25%)

XPEV Xpeng
$49.42 /

-2.065 (-4.01%)

WKHS Workhorse Group
$22.07 /

-0.585 (-2.58%)

TSLA Tesla
$599.00 /

+5.95 (+1.00%)

QSR Restaurant Brands
$60.50 /

+1.68 (+2.86%)

PLUG Plug Power
$24.85 /

+1 (+4.19%)

NKLA Nikola
$18.86 /

-0.14 (-0.74%)

NIO NIO Inc.
$43.01 /

-2.29 (-5.06%)

BLNK Blink Charging
$23.84 /

+1.19 (+5.25%)

XPEV Xpeng
$49.42 /

-2.065 (-4.01%)

WKHS Workhorse Group
$22.07 /

-0.585 (-2.58%)

TSLA Tesla
$599.00 /

+5.95 (+1.00%)

QSR Restaurant Brands
$60.50 /

+1.68 (+2.86%)

PLUG Plug Power
$24.85 /

+1 (+4.19%)

NKLA Nikola
$18.86 /

-0.14 (-0.74%)

NIO NIO Inc.
$43.01 /

-2.29 (-5.06%)

GM General Motors
$44.38 /

+0.31 (+0.70%)

BLNK Blink Charging
$23.84 /

+1.19 (+5.25%)

Periodicals
Salesforce paying huge price for Slack, deal might not work, Barron's says » 08:38
12/05/20
12/05
08:38
12/05/20
08:38
CRM

Salesforce

$225.50 /

+4.54 (+2.05%)

, WORK

Slack Technologies

$42.78 /

+0.29 (+0.68%)

, MSFT

Microsoft

$214.39 /

+0.12 (+0.06%)

Salesforce (CRM) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$42.78 /

+0.29 (+0.68%)

MSFT Microsoft
$214.39 /

+0.12 (+0.06%)

CRM Salesforce
$225.50 /

+4.54 (+2.05%)

CRM Salesforce
$225.50 /

+4.54 (+2.05%)

12/03/20 Wedbush
Slack Technologies upgraded to Neutral from Underperform at Wedbush
12/02/20 Needham
Salesforce Q3 results were 'mildly disappointing', says Needham
12/02/20 Citi
Citi not a fan of Slack acquisition, downgrades Salesforce to Neutral
12/02/20 Raymond James
Salesforce price target raised to $280 from $255 at Raymond James
WORK Slack Technologies
$42.78 /

+0.29 (+0.68%)

12/02/20 Cowen
Slack Technologies downgraded to Market Perform from Outperform at Cowen
MSFT Microsoft
$214.39 /

+0.12 (+0.06%)

12/04/20 DA Davidson
Okta price target raised to $300 from $250 at DA Davidson
12/02/20 Stephens
Stephens upgrades ACI Worldwide to Overweight after Starboard urges sale
12/02/20 Stephens
Slack Technologies downgraded to Equal Weight from Overweight at Stephens
WORK Slack Technologies
$42.78 /

+0.29 (+0.68%)

MSFT Microsoft
$214.39 /

+0.12 (+0.06%)

CRM Salesforce
$225.50 /

+4.54 (+2.05%)

MSFT Microsoft
$214.39 /

+0.12 (+0.06%)

CRM Salesforce
$225.50 /

+4.54 (+2.05%)

WORK Slack Technologies
$42.78 /

+0.29 (+0.68%)

MSFT Microsoft
$214.39 /

+0.12 (+0.06%)

CRM Salesforce
$225.50 /

+4.54 (+2.05%)

WORK Slack Technologies
$42.78 /

+0.29 (+0.68%)

MSFT Microsoft
$214.39 /

+0.12 (+0.06%)

CRM Salesforce
$225.50 /

+4.54 (+2.05%)

Downgrade
Canadian Western Bank downgraded to Market Perform at BMO Capital » 08:37
12/05/20
12/05
08:37
12/05/20
08:37
CBWBF

Canadian Western Bank

$0.00 /

+ (+0.00%)

BMO Capital analyst…

BMO Capital analyst Sohrab Movahedi downgraded Canadian Western Bank to Market Perform from Outperform with a price target of C$31, down from C$36. The analyst believes the company's elevated expenses in fiscal 2021 warrants a downgrade.

ShowHide Related Items >><<
CBWBF Canadian Western Bank
$0.00 /

+ (+0.00%)

11/23/20 Scotiabank
Canadian Western Bank price target raised to C$33 from C$29 at Scotiabank
11/18/20 National Bank
Canadian Western Bank price target raised to C$30 from C$28 at National Bank
10/28/20 Raymond James
Canadian Western Bank initiated with an Outperform at Raymond James
09/09/20 Barclays
Canadian Western Bank price target raised to C$30 from C$27 at Barclays
Periodicals
DoorDash has been a COVID winner, IPO might not be, Barron's says » 08:31
12/05/20
12/05
08:31
12/05/20
08:31
DASH

DoorDash

$0.00 /

+ (+0.00%)

DoorDash is going public…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$0.00 /

+ (+0.00%)

12/01/20
Fly Intel: Top five analyst initiations
12/01/20 Loop Capital
Uber price target raised to $59 from $40 at Loop Capital
12/01/20 DA Davidson
DoorDash initiated with a Buy at DA Davidson
07/08/20 Wedbush
Postmates stronger fit for Uber, less market share than GrubHub, says Wedbush
  • 09
    Dec
DASH DoorDash
$0.00 /

+ (+0.00%)

DASH DoorDash
$0.00 /

+ (+0.00%)

Periodicals
Airbnb's IPO will be hot, stock worth the price, Barron's says » 08:20
12/05/20
12/05
08:20
12/05/20
08:20
ABNB

Airbnb

$0.00 /

+ (+0.00%)

Airbnb could be one of…

Airbnb could be one of the hottest initial public offerings of the year, Andrew Bary writes in this week's edition of Barron's. With its asset-light business model and global presence, the company is poised to benefit from a rebound in travel, the author notes. While the proposed market value of Airbnb - around $30B at the top of the proposed pricing range of $44-$50 a share - isn't cheap, valuation looks reasonable given the company's market position, scarcity value, brand power, and global opportunity at a time when investors regularly value exciting growth companies at considerably more than 10 times annual sales, Bary adds. Reference Link

ShowHide Related Items >><<
ABNB Airbnb
$0.00 /

+ (+0.00%)

ABNB Airbnb
$0.00 /

+ (+0.00%)

12/02/20
Fly Intel: Top five analyst initiations
12/02/20 Atlantic Equities
Atlantic Equities starts Airbnb with Overweight, $75 price target
12/02/20 Atlantic Equities
Airbnb initiated with an Overweight at Atlantic Equities
  • 10
    Dec
ABNB Airbnb
$0.00 /

+ (+0.00%)

ABNB Airbnb
$0.00 /

+ (+0.00%)

On The Fly
Week in review: How Trump's policies moved stocks » 08:08
12/05/20
12/05
08:08
12/05/20
08:08
TWTR

Twitter

$47.74 /

-0.06 (-0.13%)

, FB

Facebook

$279.65 /

-2.04 (-0.72%)

, AAPL

Apple

$122.23 /

-0.71 (-0.58%)

, HNHPF

Hon Hai Precision

$0.00 /

+ (+0.00%)

Catch up on the top…

ShowHide Related Items >><<
TWTR Twitter
$47.74 /

-0.06 (-0.13%)

HNHPF Hon Hai Precision
$0.00 /

+ (+0.00%)

FB Facebook
$279.65 /

-2.04 (-0.72%)

AAPL Apple
$122.23 /

-0.71 (-0.58%)

TWTR Twitter
$47.74 /

-0.06 (-0.13%)

11/16/20 BofA
Comcast, Eaton, Nice & Twitter added to US 1 List at BofA
11/02/20 Citi
Twitter price target raised to $42 from $36 at Citi
10/30/20 Oppenheimer
Twitter price target raised to $55 from $46 at Oppenheimer
10/30/20 Deutsche Bank
Twitter price target raised to $64 from $56 at Deutsche Bank
FB Facebook
$279.65 /

-2.04 (-0.72%)

11/27/20 Truist
Amazon to claim 42c of every e-commerce dollar spent, says Truist
11/27/20 MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
10/30/20 Raymond James
Facebook price target raised to $320 from $280 at Raymond James
10/30/20 Canaccord
Facebook price target raised to $330 from $315 at Canaccord
AAPL Apple
$122.23 /

-0.71 (-0.58%)

12/04/20 BWS Financial
AXT Inc. news on Osram could imply win at Apple, says BWS Financial
12/01/20 Raymond James
Apple Store 'not a new channel' for Arlo Technologies, says Raymond James
12/01/20 Credit Suisse
Modest uptick in iPhone 12 Pro waits, Pro Max remains stable, says Credit Suisse
11/30/20
Fly Intel: Top five analyst upgrades
HNHPF Hon Hai Precision
$0.00 /

+ (+0.00%)

02/24/20 Morgan Stanley
Hon Hai Precision upgraded to Overweight from Equal Weight at Morgan Stanley
TWTR Twitter
$47.74 /

-0.06 (-0.13%)

FB Facebook
$279.65 /

-2.04 (-0.72%)

AAPL Apple
$122.23 /

-0.71 (-0.58%)

TWTR Twitter
$47.74 /

-0.06 (-0.13%)

HNHPF Hon Hai Precision
$0.00 /

+ (+0.00%)

FB Facebook
$279.65 /

-2.04 (-0.72%)

AAPL Apple
$122.23 /

-0.71 (-0.58%)

TWTR Twitter
$47.74 /

-0.06 (-0.13%)

FB Facebook
$279.65 /

-2.04 (-0.72%)

AAPL Apple
$122.23 /

-0.71 (-0.58%)

TWTR Twitter
$47.74 /

-0.06 (-0.13%)

FB Facebook
$279.65 /

-2.04 (-0.72%)

AAPL Apple
$122.23 /

-0.71 (-0.58%)

Conference/Events
Lowe's to host virtual analyst day » 21:00
12/04/20
12/04
21:00
12/04/20
21:00
LOW

Lowe's

$150.00 /

-1.845 (-1.22%)

Virtual Analyst Day to be…

Virtual Analyst Day to be held on December 9 at 8 am. Webcast Link

ShowHide Related Items >><<
LOW Lowe's
$150.00 /

-1.845 (-1.22%)

LOW Lowe's
$150.00 /

-1.845 (-1.22%)

12/04/20 Morgan Stanley
Lowe's, Home Depot price targets raised at Morgan Stanley
11/18/20 Baird
Lowe's Q3 comps 'robust', Q4 EBIT margin guidance 'flattish', says Baird
11/18/20 Wells Fargo
Lowe's long-term transformation making progress, says Wells Fargo
11/18/20 Baird
Lowe's pullback likely a buying opportunity, says Baird
LOW Lowe's
$150.00 /

-1.845 (-1.22%)

LOW Lowe's
$150.00 /

-1.845 (-1.22%)

LOW Lowe's
$150.00 /

-1.845 (-1.22%)

LOW Lowe's
$150.00 /

-1.845 (-1.22%)

Hot Stocks
Crowdstrike CEO: Target is a great partner for us » 18:35
12/04/20
12/04
18:35
12/04/20
18:35
CRWD

Crowdstrike

$167.35 /

+6.15 (+3.82%)

In an interview on…

In an interview on CNBC's Mad Money, George Kurtz said, "Target is a marquee name and we are proud to have them as a customer." Crowdstrike protects many of the large pharmaceutical companies, Kurtz noted. COVID-19 has prompted a number of malware/phishing attacks, and the threat environment continues to get worse, he said. The trend of companies moving to the cloud is sustainable and Crowdstrike is well-positioned to take advantage of that, Kurtz added.

ShowHide Related Items >><<
CRWD Crowdstrike
$167.35 /

+6.15 (+3.82%)

CRWD Crowdstrike
$167.35 /

+6.15 (+3.82%)

12/04/20 Credit Suisse
Crowdstrike price target raised to $150 from $125 at Credit Suisse
12/04/20 BTIG
Crowdstrike price target raised to $190 from $164 at BTIG
12/03/20 FBN Securities
Crowdstrike price target raised to $200 from $150 at FBN Securities
12/03/20 DA Davidson
Crowdstrike price target raised to $185 from $160 at DA Davidson
CRWD Crowdstrike
$167.35 /

+6.15 (+3.82%)

  • 26
    Jun
  • 07
    Jan
  • 09
    Dec
CRWD Crowdstrike
$167.35 /

+6.15 (+3.82%)

CRWD Crowdstrike
$167.35 /

+6.15 (+3.82%)

CRWD Crowdstrike
$167.35 /

+6.15 (+3.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.